Prostatype Genomics AB

Prostatype Genomics AB financial statements

Prostatype Genomics AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueSEK 594KEODHD
Net income−SEK 44.5MEODHD
Cash and equivalentsSEK 9.07MEODHD
Total debtSEK 5.3MEODHD

Prostatype Genomics AB financials on 6ix · Prostatype Genomics AB on 6ix